Inflammatory bowel diseases: A dysfunction of brain-gut interactions?

Minerva Gastroenterologica e Dietologica

Volumn 59, Issue 3, 2013, Pages 241-259

  Bonaz, B ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Autonomic nervous system; Brain gut interactions; Depression; Inflammatory bowel diseases; Stress, psychological

Indexed keywords

AMITRIPTYLINE; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CHOLINERGIC RECEPTOR; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; DESIPRAMINE; INDOMETACIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NONSTEROID ANTIINFLAMMATORY AGENT; PEPTIDOGLYCAN POLYSACCHARIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UROCORTIN I; UROCORTIN II; UROCORTIN III;

ADRENERGIC SYSTEM; ALLERGIC ASTHMA; ALTERNATIVE MEDICINE; AMYGDALOID NUCLEUS; ANTIINFLAMMATORY ACTIVITY; AUTONOMIC DYSFUNCTION; BLOOD BRAIN BARRIER; BRAIN GUT INTERACTION DYSFUNCTION; BRAIN STEM; CELL LOSS; CEREBELLUM; CHOLINERGIC SYSTEM; CHRONIC FATIGUE SYNDROME; CHRONIC STRESS; CONSCIOUSNESS; CONVULSIVE THERAPY; CROHN DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; DEPRESSION; DOWN REGULATION; EARLY LIFE STRESS; ENDOTOXEMIA; ENTERITIS; FATIGUE; FIBROMYALGIA; GANGLION; HIPPOCAMPUS; HUMAN; HUMORAL IMMUNITY; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; INFERIOR MESENTERIC GANGLION; INSOMNIA; INTELLECT; INTESTINE FLORA; LOCUS CERULEUS; MACROPHAGE; MAST CELL; MATERNAL DEPRIVATION; MEDIAL FOREBRAIN BUNDLE; MENTAL STRESS; MESENCEPHALON; MYENTERIC PLEXUS; NEGATIVE FEEDBACK; NEOCORTEX; NERVE CELL PLASTICITY; NONHUMAN; OLFACTORY BULBECTOMY; ORBITAL CORTEX; PARABRACHIAL NUCLEUS; PARASYMPATHETIC NERVE CELL; PARASYMPATHETIC TONE; PERIAQUEDUCTAL GRAY MATTER; POSTNATAL DEVELOPMENT; PREFRONTAL CORTEX; PREGANGLIONIC NERVE CELL; PRENATAL STRESS; PSYCHOTHERAPY; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SOLITARY TRACT NUCLEUS; SPINAL CORD DORSAL HORN; SPINOTHALAMIC TRACT; SPLANCHNIC NERVE; SPLEEN; SPLEEN CELL; SPLENECTOMY; STOMACH EMPTYING; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; THALAMUS; ULCERATIVE COLITIS; UPREGULATION; VAGUS NERVE; VAGUS REFLEX;

BRAIN; DEPRESSION; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTESTINES; MICROBIOTA; STRESS, PSYCHOLOGICAL;

EID: 84885073647     PISSN: 1121421X     EISSN: 18271642     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol 2012;9:286-94.
2. Neunlist M, Van Landeghem L, Mahé MM, Derkinderen P, des Varannes SB, Rolli-Derkinderen M. The digestive neuronal-glial-epithelial unit: a new actor in gut health and disease. Nat Rev Gastroenterol Hepatol 2013;10:90-100.
3. Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012;9:599-608.
4. Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology 2013;144:36-49.
5. Mulak A, Bonaz B. Irritable bowel syndrome: a model of the brain-gut interactions. Med Sci Monit 2004;10:RA55-RA62. (Pubitemid 38525092)
6. Pellissier S, Dantzer C, Canini F, Mathieu N, Bonaz B. Psychological adjustment and autonomic disturbances in inflammatory bowel diseases and irritable bowel syndrome. Psychoneuroendocrinology 2010;35:653-62.
7. Bonaz B, Picq C, Sinniger V,ol JF, Clarençon D. Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway. Neurogastroenterol Motil 2013;25:208-21.
8. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29. (Pubitemid 34851835)
9. Bitton A, Dobkin P, Edwardes MD, 2 Predicting relapse in Crohn's disease: a biopsychosocial model. Gut 2008;57:1386-92.
10. Mayer EA, Naliboff BD, Chang L, Coutinho SV. V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2001;280.G519-24.
11. Prechtl JC, Powley TL. The fiber composition of the abdominal vagus of the rat. Anat Embryol (Berl) 1990;181:101-15. (Pubitemid 20096971)
12. Benarroch EE. The central autonomic network: functional organization, dysfunction, and perspective. Clin Proc 1993;68:988-1001.
13. Altschuler SM, Ferenci DA, Lynn RB, Miselis RR. Representation of the cecum in the lateral dorsal motor nucleus of the vagus nerve and commissural subnucleus of the nucleus tractus solitarii in rat. J Comp Neurol 1991;304:261-74.
14. Altschuler SM, Escardo J, Lynn RB, Miselis RR. The central organization of the vagus nerve innervating the colon of the rat. Gastroenterology 1993;104:502-9. (Pubitemid 23033423)
15. Berthoud HR, Carlson NR, Powley TL. Topography of efferent vagal innervation of the rat gastrointestinal tract. Am J Physiol 1991;260(1 Pt 2):R200-7.
16. Willis WD, Al-Chaer ED, Quast MJ, Westlund KN. A visceral pain pathway in the dorsal column of the spinal cord. Proc Natl Acad Sci U S A 1999;96:7675-9. (Pubitemid 29328339)
17. Mason P.onstructing endogenous pain modulations. J Neurophysiol 2005;94:1659-63.
18. Perl ER. Pain mechanisms: a commentary on concepts and issues. Prog Neurobiol 2011;94:20-38.
19. Cottrell GT, Ferguson AV. Sensory circumventricular organs: central roles in integrated autonomic regulation. Regul Pept 2004 15;117:11-23.
20. Gaykema RP, Dijkstra I, Tilders FJ. Subdiaphragmatic vagotomy suppresses endotoxin-induced activation of hypothalamic corticotropin-releasing hormone neurons and ACTH secretion. Endocrinology 1995;136:4717-20.
21. Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol 2002;20:125-63. (Pubitemid 34295785)
22. Gunnar M, Quevedo K. The neurobiology of stress and development. Annu Rev Psychol 2007;58:145-73.
23. Straub RH, Herfarth H, Falk W, 2 Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenalaxis in inflammatory bowel disease? J Neuroimmunol 2002;126:116-25. (Pubitemid 34521737)
24. Borovikova LV, Ivanova S, Zhang M, 2 Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458-62. (Pubitemid 30367422)
25. Ghia JE, Blennerhassett P, Collins SM. Vagus nerve integrity and experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2007;293.G560-7. (Pubitemid 47435388)
26. Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF, Collins SM. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 2006;131:1122-30. (Pubitemid 44498700)
27. Meregnani J, Clarençon D, Vivier M, 2 Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton Neurosci 2011;160:82-9.
28. Buijs RM, van der Vliet J, Garidou ML, Huitinga I, Escobar C. Spleen vagal denervation inhibits the production of antibodies to circulating antigens. PLoS One. 2008 5;3:e3152.
29. Bratton BO,telli D, McKinley MJ, Trevaks D, Anderson CR, McAllen RM. Neural regulation of inflammation: no neural connection from the vagus to splenic sympathetic neurons. Exp Physiol 2012;97:1180-5.
30. Huston JM, Ochani M, Rosas-Ballina M, Liao H, Ochani K, Pavlov VA et al. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobialsis. J Exp Med 2006 10;203:1623-8.
31. Rosas-Ballina M, Ochani M, Parrish WR, Ochani K, Harris YT, Huston JM et al. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci U S A 2008;105:11008-13.
32. Rosas-Ballina M, Olofsson PS, Ochani M, Valdés-Ferrer SI, Levine YA, Reardon C et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 2011;334:98-101.
33. Bonaz B, Pellissier S, Sinniger V, Clarençon D, Pennequin A, Canini F. The irritable bowel syndrome: how stress can affect the amygdala activity and the brain-gut axis. In: Barbara Ferry B, editor. (Ed.) The amygdala - A discrete multitasking manager. InTech 2012; Chapter 14. p. 339-74.
34. LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci 2000;23:155-84. (Pubitemid 30350041)
35. Gray TS. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann N Y Acad Sci 1993;697:53-60. (Pubitemid 24028954)
36. Pechtel P, Pizzagalli DA. Effects of early life stress on cognitive and affective function: an integrated review of human literature. Psychopharmacology (Berl) 2011;214:55-70.
37. Myers B, Greenwood-Van Meerveld B. Elevated corticosterone in the amygdala leads to persistent increases in anxiety-like behavior and pain sensitivity. Behav Brain Res 2010;214:465-9.
38. Sotres-Bayon F, Quirk GJ. Prefrontal control of fear: more than just extinction. Curr Opin Neurobiol 2010;20:231-5.
39. Wellman CL. Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. J Neurobiol 2001 15;49:245-53.
40. Pérez-Jaranay JM, Vives F. Electrophysiological study of the response of medial prefrontal cortex neurons to stimulation of the basolateral nucleus of the amygdala in the rat. Brain Res 1991 8;564:97-101.
41. Garcia R, Vouimba RM, Baudry M, Thompson RF. The amygdala modulates prefrontal cortex activity relative to conditioned fear. Nature 1999;402:294-6. (Pubitemid 129516265)
42. An X, Bandler R, Ongür D, Price JL. Prefrontal cortical projections to longitudinal columns in the midbrain periaqueductal gray in macaque monkeys. J Comp Neurol 1998;401:455-79. (Pubitemid 28509880)
43. Hillhouse EW, Grammatopoulos DK. The molecular mechanisms underlying the regulation of the biological activity of corticotropinreleasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev 2006;27:260-86.
44. Chatzaki E, Crowe PD, Wang L, 2 CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon. J Neurochem 2004;90:309-16. (Pubitemid 38938216)
45. Porcher C, Peinnequin A, Pellissier S, Meregnani J, Sinniger V, Canini F et al. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum. Peptides 2006;27:1464-75. (Pubitemid 43767011)
46. Taché Y, Bonaz B. Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 2007;117:33-40. (Pubitemid 46048447)
47. Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005;54:1481-91. (Pubitemid 41375207)
48. Kiank C, Taché Y, Larauche M. Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors. Brain Behav Immun 2010;24:41-8.
49. Yuan PQ, Wu SV, Elliott J, Anton PA, Chatzaki E, Million M et al. Expression of corticotropin releasing factor receptor type 1 (CRF1) in the human gastrointestinal tract and upregulation in the colonic mucosa in patients with ulcerative colitis. Peptides 2012;38:62-9.
50. Chatzaki E, Anton PA, Million M, Lambropoulou M, Constantinidis T, Kolios G et al. Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitis. World J Gastroenterol 2013 7;19:1416-23.
51. Moss AC, Anton P, Savidge T, Newman P, Cheifetz AS, Gay J et al. Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha. Gut 2007;50:1210-7. (Pubitemid 47300420)
52. Larauche M, Kiank C, Tache Y. Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications. J Physiol Pharmacol 2009;60(Suppl 7):33-46.
53. Straub RH, Wiest R, Strauch UG. The role of the sympathetic nervous system in intestinal inflammation. Gut 2006;55:1640-9. (Pubitemid 44629216)
54. Wood SK, Woods JH. Corticotropin-releasing factor receptor-1: a therapeutic target for cardiac autonomic disturbances. Expert Opin Ther Targets 2007;11:1401-13. (Pubitemid 350200477)
55. Bonaz B, Rivest S. Effect of a chronic stress on CRF neuronal activity and expression of its type 1 receptor in the rat brain. Am J Physiol 1998;275:R1438-R1449.
56. Qiu BS, Vallance BA, Blennerhassett PA. The role of CD4 lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. Nat Med 1999;5:1178-1182. (Pubitemid 29474423)
57. Stonerook MJ, Weiss HS, Rodriguez MA, Rodríguez JV, Hernández JI, Peck OC, Wood JD. Temperature-metabolism relations in the cotton-top tamarin (Saguinus oedipus) model for ulcerative colitis. J Med Primatol 1994;23:16-22.
58. Bernstein CN, Singh S, Graff LA. A prospective populationbased study of symptomatic triggers of flares in IBD. Am J Gastroenterol 2010;105:1994-2002.
59. Shiga H, Miyazawa T, Kinouchi Y, Takahashi S, Tominaga G, Takahashi H et al. Life-event stress induced by the Great East Japan Earthquake was associated with relapse in ulcerative colitis but not Crohn's disease: a retrospective cohort study. BMJ Open 2013 8;3.
60. Jakobsen C, Paerregaard A, Munkholm P, Wewer V. Environmental factors and risk of developing paediatric inflammatory bowel disease - a population based study 2007-2009. J Crohns Colitis 2013;7:79-88.
61. Iglesias-Rey M, Barreiro-de Acosta M, Caamaño-Isorna F, Rodríguez IV, González AL et al. How do psychological variables influence coping strategies in inflammatory bowel disease? J Crohns Colitis 2013;7:e219-26.
62. Kuroki T, Ohta A, Sherriff-Tadano R, Matsuura E, Takashima T, Iwakiri R et al. Imbalance in the stress-adaptation system in patients with inflammatory bowel disease. Biol Res Nurs 2011;13:391-8.
63. Darnaudéry M, Maccari S. Epigenetic programming of the stress response in male and female rats by prenatal restraint stress. Brain Res Rev 2008;57:571-85.
64. Morley-Fletcher S, Rea M, Maccari S, Laviola G. Environmental enrichment during adolescence reverses the effects of prenatal stress on play behaviour and HPA axis reactivity in rats. Eur J Neurosci 2003;18:3367-74. (Pubitemid 38031062)
65. Talge NM, Neal C, Glover V. Early Stress, Translational Research and Prevention Science Network: Fetal and Neonatal Experience on Child and Adolescent Mental Health. Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? J Child Psychol Psychiatry 2007;48:245-61.
66. Vanbesien-Mailliot CC, Wolowczuk I, Mairesse J, Viltart O, Delacre M, Khalife J et al. Prenatal stress has pro-inflammatory consequences on the immune system in adult rats. Psychoneuroendocrinology 2007;32:114-24. (Pubitemid 46274014)
67. Diz-Chaves Y, Pernía O, Carrero P, Garcia-Segura LM. Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice. J Neuroinflammation 2012;9:71.
68. Hodyl NA, Krivanek KM, Lawrence E, Clifton VL, Hodgson DM. Prenatal exposure to a pro-inflammatory stimulus causes delays in the development of the innate immune response to LPS in the offspring. J Neuroimmunol 2007;190:61-71. (Pubitemid 47625608)
69. Anda RF, Felitti VJ, Bremner JD, Walker JD, Whitfield C, Perry BD et al. The enduring effects of abuse and related adverse experiences in childhood. A convergence of evidence from neurobiology and epidemiology. Eur Arch Psychiatry Clin Neurosci 2006;256:174-86.
70. Walker EA, Gelfand AN, Gelfand MD, Katon WJ. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psychol Med 1995;25.1259-67.
71. Lenroot RK, Schmitt JE, Ordaz SJ, Wallace GL, Neale MC, Lerch JP et al. Differences in genetic and environmental influences on the human cerebral cortex associated with development during childhood and adolescence. Hum Brain Mapp. 2009;30:163-74.
72. Lenroot RK, Giedd JN. Sex differences in the adolescent brain. Brain Cogn 2010;72:46-55.
73. Tottenham N, Sheridan MA. A review of adversity, the amygdala and the hippocampus: a consideration of developmental timing. Front Hum Neurosci 2010;3:68.
74. Brake WG, Sullivan RM, Gratton A. Perinatal distress leads to lateralized medial prefrontal cortical dopamine hypofunction in adult rats. J Neurosci 2000;20:5538-43. (Pubitemid 30457750)
75. Adolphs R. Recognizing emotion from facial expressions: psychological and neurological mechanisms. Behav Cogn Neurosci Rev 2002;1:21-62.
76. Kim MJ, Whalen PJ. The structural integrity of an amygdala-prefrontal pathway predicts trait anxiety. J Neurosci 2009;29:11614-8.
77. Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis 2009;15:1105-18.
78. Stein M, Keller SE, Schleifer SJ. Stress and immunomodulation: the role of depression and neuroendocrine function. J Immunol 1985;135(2 Suppl):827s-833s. (Pubitemid 16229440)
79. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31. (Pubitemid 43083561)
80. Raison CL, Miller AH. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 2003;160:1554-65. (Pubitemid 41079539)
81. Pariante CM, Miller AH. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001;49:391-404. (Pubitemid 32234301)
82. Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 2001;11:240-9. (Pubitemid 32289413)
83. Duman RS. Depression: a case of neuronal life and death? Biol Psychiatry 2004 1;56:140-5.
84. Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 2004;500:399-411. (Pubitemid 39304023)
85. Dunn AJ, Wang J, Ando T. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv Exp Med Biol 1999;461:117-27.
86. Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the "kindling" hypothesis. Am J Psychiatry 2000;157:1243-51. (Pubitemid 30662071)
87. O'Connor KA, Johnson JD, Hansen MK, Wieseler Frank JL, Maksimova E, Watkins LR et al. Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Res 2003;991:123-32. (Pubitemid 37297941)
88. Madrigal JL, Hurtado O, Moro MA, Lizasoain I, Lorenzo P, Castrillo A et al. The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology 2002;26:155-63. (Pubitemid 34093078)
89. Pavlov VA, Wang H, Czura CJ, Friedman SG, Tracey KJ. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 2003,9:125-34. (Pubitemid 37310949)
90. Janszky I, Ericson M, Lekander M, Blom M, Buhlin K, Georgiades A et al. Inflammatorykers and heart rate variability in women with coronary heart disease. J Intern Med 2004;256:421-8. (Pubitemid 39434379)
91. Kim CK, McGorray SP, Bartholomew BA, sh M, Dicken T, Wassertheil-Smoller S, Curb JD, Oberman A, Hsia J, Gardin J, Wong ND, Barton B, McMahon RP, Sheps DS. Depressive symptoms and heart rate variability in postmenopausal women. Arch Intern Med. 2005 13;165:1239-44.
92. Kenis G, Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 2002;5:401-12. (Pubitemid 35470359)
93. Mikocka-Walus AA, Gordon AL, Stewart BJ. A magic pill? A qualitative analysis of patients' views on the role of antidepressant therapy in inflammatory bowel disease (IBD). BMC Gastroenterol 2012;12:93.
94. Rahimi HR, Shiri M, Razmi A. Antidepressants can treat inflammatory bowel disease through regulation of the nuclear factor-κB/nitric oxide pathway and inhibition of cytokine production: A hypothesis. World J Gastrointest Pharmacol Ther 2012;3:83-5.
95. Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 2007;21:374-83. (Pubitemid 46528684)
96. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-56. (Pubitemid 350295688)
97. Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ. Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biol Psychiatry 2012 1;71:15-21.
98. Varghese AK, Verdú EF, Bercik P, Khan WI, Blennerhassett PA, Szechtman H et al. Antidepressants attenuate increased susceptibility to colitis in a murine model of depression. Gastroenterology 2006;130:1743-53. (Pubitemid 43668855)
99. Ghia JE, Blennerhassett P, Deng Y, Verdu EF, Khan WI, Collins SM. Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology 2009;136:2280-8.
100. Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004 1;558(Pt 1):263-75.
101. Bercik P, Denou E, Collins J. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011;141:599-609.
102. .Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 2011;23:1132-9.
103. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 2011;108:16050-5.
104. Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B et al. Consumption of Fermented Milk Product with Probiotic Modulates Brain Activity. Gastroenterology 2013;144:1394-1401.e4